NCT00159692View on ClinicalTrials.gov

Amlodipine Diabetic Hypertension Efficacy Response Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

739

Participants

Timeline

Start Date

March 31, 2003

Study Completion Date

August 31, 2005

Conditions
Hypertension
Interventions
DRUG

Amlodipine

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00159692 - Amlodipine Diabetic Hypertension Efficacy Response Trial | Biotech Hunter | Biotech Hunter